Dr James Dennis Scott, MD | |
300 Independence Ln, Roseburg, OR 97471-9540 | |
(541) 673-3259 | |
Not Available |
Full Name | Dr James Dennis Scott |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 300 Independence Ln, Roseburg, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619128246 | NPI | - | NPPES |
177352 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD07736 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James Dennis Scott, MD 300 Independence Ln, Roseburg, OR 97471-9540 Ph: (541) 673-3259 | Dr James Dennis Scott, MD 300 Independence Ln, Roseburg, OR 97471-9540 Ph: (541) 673-3259 |
News Archive
After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs called thiazolidinediones (TZDs), used to treat type 2 diabetes.
Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.
Oklahoma has opted not to proceed with a state-based exchange or with the Medicaid expansion, while Republican governors from Tennessee, Utah and Iowa continue to press the Department of Health and Human Services for more guidance.
An intensivist-led, multidisciplinary rapid-response team with extended involvement in patient care yields multiple benefits, say researchers.
A U.S. advisory panel has recommended that drugs used by millions to treat attention deficit hyperactivity disorder (ADHD), should carry a warning of the risk of heart problems.
› Verified 4 days ago
James M Yun, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2423 Nw Troost St, Roseburg, OR 97471 Phone: 541-677-3400 Fax: 541-677-3405 | |
Tyson Jarad Dahl, PA-C Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2423 Nw Troost St, Roseburg, OR 97471 Phone: 541-677-3400 Fax: 541-677-3405 | |
Carl S Schreiner, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2423 Nw Troost St, Roseburg, OR 97471 Phone: 541-677-3400 Fax: 541-677-3405 | |
David E. Owens, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1813 W Harvard Ave, Suite 201, Roseburg, OR 97471 Phone: 541-440-6390 Fax: 541-440-6392 |